Create Alert
Watchlist

Sun Pharmaceutical Industries

1231.25
+5.40 (0.44%) 1D
NSE
1D
1W
1M
1Y
3Y
5Y
All

Performance

Open
1,233.05
Prev. Close
1,225.85
Volume
17,49,751
Total traded value
215 Cr
Upper Circuit
1,354.35
Lower Circuit
1,108.15

Market Depth

Buy order quantity
Sell order quantity
%
%
Loading...
Bid Total
0
Loading...
Ask Total
66

Analyst Estimates

89%
Buy
89%
Hold
6%
Sell
6%
Aggregated by Refinitiv from 35 Analysts

Fundamentals

Market Cap₹2,95,418Cr
ROE14.29%
P/E Ratio(TTM)34.56
EPS(TTM)35.63
P/B Ratio4.94
Dividend Yield0.93%
Industry P/E32.29
Book Value249.34
Debt to Equity0.03
Face Value1
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Sun Pharmaceutical

Sun Pharmaceutical Industries Limited is an India-based specialty generic pharmaceutical company. The Company is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulation and active pharmaceutical ingredients (APIs). It produces a comprehensive, diverse and complementary portfolio of generic and specialty medicines targeting a wide spectrum of chronic and acute treatments. The Company's vertically integrated network enables it to produce a wide range of pharmaceuticals, including oncology, hormones, peptides, and steroidal drugs. The Company also has a product portfolio in RoW markets, including injectables, hospital products and retail products. It offers a variety of dosage forms, including orals, creams, ointments, injectables, sprays, and liquids. Its marketed specialty portfolio includes Ilumya/ Ilumetri, Winlevi, Levulan Kerastick + BLU-U, Absorica LD, Odomzo, Cequa, Bromsite, Xelpros, Yonsa, Sezaby and Sprinkle portfolio. ;
Parent OrganisationSun Pharmaceutical Industries Limited
Founded1993
Managing DirectorNA
NSE SymbolSUNPHARMA

Shareholding Pattern

Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Promoters
54.48%
Foreign Institutions
16.78%
Mutual Funds
13.07%
Retail And Others
10.51%
Other Domestic Institutions
5.16%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Cipla
₹1,205.70
(-0.54%)
28.21
Dr Reddy's Laboratories
₹5,749.40
(0.00%)
18.83
Mankind Pharma
NA
(0.00%)
49.31
Torrent Pharmaceuticals
NA
(0.00%)
54.22
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.5.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ

ABOUT GROWW